We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Koninklijke Philips NV | NYSE:PHG | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.06 | 0.22% | 26.88 | 26.93 | 26.53 | 26.88 | 1,798,318 | 21:02:28 |
By Ben Glickman
The U.S. Food and Drug Administration warned of an emerging safety issue involving a continuous positive airway pressure, or CPAP, machine made by Philips.
The FDA issued a safety communication about thermal issues with the Philips Respironics' DreamStation 2 CPAP machines, which are used to treat forms of sleep apnea, and recommended patients monitor machines.
The agency said it had received reports of issues such as fire, smoke, burns and other signs of overheating. The FDA said it is in discussions with the company about strategies to address the safety issue.
The FDA said that it noted a "sharp increase" in the number of medical device reports related to the machines between Aug. 1 and Nov. 15.
The regulator said that it continues to monitor the company's handling of a June 2021 recall involving sleep therapy and respirator machines, which was related to a foam used in certain products.
The FDA said it does not believe the safety issue is related to the foam used in the DreamStation 2.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
November 28, 2023 16:10 ET (21:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Koninklijke Philips NV Chart |
1 Month Koninklijke Philips NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions